Schizophrenia Research
Volume 84, Issue 2 , Pages 244-252 , June 2006

Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia

  • Hiromitsu Shimizu

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • ,
  • Yoshimi Iwayama

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • ,
  • Kazuo Yamada

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • ,
  • Tomoko Toyota

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • ,
  • Yoshio Minabe

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan
    • ,
  • Kauhiko Nakamura

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan
    • ,
  • Mizuho Nakajima

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • ,
  • Eiji Hattori

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • ,
  • Norio Mori

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan
    • ,
  • Noriko Osumi

      Affiliations

    • Division of Developmental Neuroscience, Center for Translational and Advanced Animal Research, Tohoku University School of Medicine, Sendai, Miyagi 980-8575, Japan
    • CREST, Japan Science and Technology Agency, Saitama, Japan
    • ,
  • Takeo Yoshikawa

      Affiliations

    • Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan
    • CREST, Japan Science and Technology Agency, Saitama, Japan
    • Corresponding Author InformationCorresponding author. Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-city, Saitama 351-0198, Japan. Tel.: +81 48 467 5968; fax: +81 48 467 7462.

Received 28 November 2005 ,Revised 6 March 2006 ,Accepted 6 March 2006.

References 

  1. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly PA. Haplotype map of the human genome. Nature. 2005;437:1299–1320
  2. Anderson SA, Volk DW, Lewis DA. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr. Res. 1996;19:111–119
  3. Andrieux A, Salin PA, Vernet M, Kujala P, Baratier J, Gory-Faure S, et al. The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev. 2002;16:2350–2364
  4. Aoki-Suzuki M, Yamada K, Meerabux J, Iwayama-Shigeno Y, Ohba H, Iwamoto K, et al. A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol. Psychiatry. 2005;57:382–393
  5. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  6. Benitez-King G, Ramirez-Rodriguez G, Ortiz L, Meza I. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr. Drug Targets. 2004;3:515–533
  7. Binder LI, Frankfurter A, Kim H, Caceres A, Payne MR, Rebhun LI. Heterogeneity of microtubule-associated protein 2 during rat brain development. Proc. Natl. Acad. Sci. U. S. A. 1984;81:5613–5617
  8. Bosc C, Annie Andrieux A, Job D. STOP proteins. Biochemistry. 2003;42:12125–12132
  9. Cotter D, Wilson S, Roberts E, Kerwin R, Everall IP. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr. Res. 2000;41:313–323
  10. Deakin FW, Simpson MD, Slater P, Hellewell JS. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia. J. Psychopharmacol. 1997;11:133–142
  11. Diaz-Nido J, Avila J. Characterization of proteins immunologically related to brain microtubule-associated protein MAP-1B in non-neural cells. J. Cell Sci. 1989;92:607–620
  12. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 2003;25:115–121
  13. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225–2229
  14. Ide M, Muratake T, Yamada K, Iwayama-Shigeno Y, Iwamoto K, Takao H, et al. Genetic and expression analyses of FZD3 in schizophrenia. Biol. Psychiatry. 2004;56:462–465
  15. Ikegawa S, Sudo K, Okui K, Nakamura Y. Isolation, characterization and chromosomal assignment of human colligin-2 gene (CBP2). Cytogenet. Cell Genet. 1995;71:182–186
  16. Jones LB, Johnson N, Byne W. Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex. Psychiatry Res. 2002;114:137–148
  17. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part II: schizophrenia. Am. J. Hum. Genet. 2003;73:34–48
  18. Papandrikopoulou A, Doll T, Tucker RP, Garner CC, Matus A. Embryonic MAP2 lacks the cross-linking sidearm sequences and dendritic targeting signal of adult MAP2. Nature. 1989;340:650–652
  19. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155:945–959
  20. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149–150
  21. Rioux L, Nissanov J, Lauber K, Bilker WB, Arnold SE. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am. J. Psychiatry. 2003;160:149–155
  22. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and neuropathology consortium. Schizophr. Res. 2000;44:151–155
  23. Tucker RP, Garner CC, Matus A. In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron. 1989;2:1245–1256
  24. van Woerkom AE. The major hallucinogens and the central cytoskeleton: an association beyond coincidence? Towards sub-cellular mechanisms in schizophrenia. Med. Hypotheses. 1990;31:7–15
  25. Yamada K, Nakamura K, Minabe Y, Iwayama-Shigeno Y, Takao H, Toyota T, et al. Association analysis of FEZ1 variants with schizophrenia in Japanese. Biol. Psychiatry. 2004;56:683–690

PII: S0920-9964(06)00107-1

doi: 10.1016/j.schres.2006.03.017

Schizophrenia Research
Volume 84, Issue 2 , Pages 244-252 , June 2006

Article Tools

* Image Usage & Resolution